Records containing: Major Depressive Disorder

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-01-11
  Study of Cerebral Function in Patients With Chronic Hepatitis C Infection Before and After Pegylated Interferon Alfa-2a and Ribavirin Therapy
• CLINICAL_TRIALS study record update · 2013-01-10
  Algorithm Guided Treatment Strategies for Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2013-01-08
  QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
• CLINICAL_TRIALS study record update · 2012-12-13
  A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features
• CLINICAL_TRIALS study record update · 2012-12-11
  Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-11-21
  Associations Between Depression and Cardiovascular Disease in Patients With Late Onset, Single Episode Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-11-20
  A Multicenter, Randomized, Double-Blind Parallel Group Placebo-Controlled Phase III,Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
• CLINICAL_TRIALS study record update · 2012-11-20
  A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Therapy
• CLINICAL_TRIALS study record update · 2012-11-20
  A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
• CLINICAL_TRIALS study record update · 2012-11-16
  Psychosocial Treatment of Depression in Parkinson's Disease
• CLINICAL_TRIALS study record update · 2012-11-01
  The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
• CLINICAL_TRIALS study record update · 2012-10-29
  A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Active Controlled, Parallel Group, Multicenter Study to Assess the Safety and Efficacy of 2 Fixed Dose Groups of TC-5214 (S-mecamylamine) as Monotherapy Treatment in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
• CLINICAL_TRIALS study record update · 2012-10-29
  A Multicenter, Randomized, Double-Blind Parallel Group Placebo-Controlled Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressants in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
• CLINICAL_TRIALS study record update · 2012-10-29
  A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III, Long-Term Safety and Tolerability Study of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant in Patients With Major Depressive Disorder Who Exhibit an Inadequate Response to Antidepressant Therapy
• CLINICAL_TRIALS study record update · 2012-10-26
  Aripiprazole Augmentation of SSRI Antidepressant Therapy in Treatment Refractory Depression: Assessment of Symptom Reduction, Psychosocial Function, and Cognitive Function
• CLINICAL_TRIALS study record update · 2012-10-26
  Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
• CLINICAL_TRIALS study record update · 2012-10-15
  A Randomized Controlled Trial of Cognitive Behavior Therapy Provided by Buddhist Monks vs. Treatment as Usual in the Treatment of Late Life-depression
• CLINICAL_TRIALS study record update · 2012-10-08
  Brain Imaging of Psychotherapy for Depression (Includes, "Reward System Recovery Following Behavioral Activation Therapy in Depression")
• CLINICAL_TRIALS study record update · 2012-09-27
  A Phase IIa, Multi-centre, Randomized, Double-Blind, Double-Dummy, Active and Placebo Controlled, Parallel Group Study to Assess the Effectiveness and Safety of AZD2066 After 6 Weeks of Treatment in Patients With Major Depressive Disorder - D0475C00020
• CLINICAL_TRIALS study record update · 2012-09-21
  Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy
• CLINICAL_TRIALS study record update · 2012-09-12
  Randomized, Double Blind, Placebo Controlled, Single IV Dose Parallel Efficacy and Safety Study of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants During the Current Episode of Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-09-11
  Incidence and Prevalence of and Factors Associated With Metabolic Syndrome and Thyroid Dysfunction in Patients With Major Depressive Disorder
• CLINICAL_TRIALS study record update · 2012-09-11
  Phase IIa Study of Antidepression Use Natural Plants Extracted of Soline Capsule.
• CLINICAL_TRIALS study record update · 2012-08-31
  Open Label, Observational, Non-interventional Study for the Evaluation of Remission Rates in Patients With MDD Under Treatment With Various Anti-depressives
• CLINICAL_TRIALS study record update · 2012-08-17
  A Long-Term, Open-label Extension Study of F2695 SR in Adult Patients With Major Depressive Disorder